Company-wide revenue
Reported revenue in 2023 ¥1.19B Reported revenue in 2025 ¥1.62B
- growth amount
- +¥434.6M
- growth annualized
- +16.8%
- growth total
- +36.5%
Japanese company profile · 189A
D&M Kanpanii
In its FY2025 public filing, D&M Kanpanii reports Management support for medical institutions. The page shows business-level revenue and profit where the source disclosures support comparison.
Romanized spelling of the Japanese company name; not an official English name.
Original Japanese company name: 株式会社Ｄ＆Ｍカンパニー
Reported company-wide figures
What does this company do?
What does this company do?
D&M Kanpanii's largest reported business by revenue in FY2025 was Management support for medical institutions.
The business with the highest reported segment profit in FY2025 was Management support for medical institutions.
FY2025 · fiscal year ended May 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Management support for medical institutions | ¥1.62B ↗ | 100.0% | ¥272.35M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended May 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Management support for medical institutions
- 医療機関等に対する経営サポート事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Management support for medical institutions
- 医療機関等に対する経営サポート事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Management support for medical institutions | ¥1.19B | ¥1.5B | ¥1.62B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended May 2026
The source document may be in Japanese.
Filing ID: S100YZ57
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.